Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin

Detalles Bibliográficos
Autores principales: Liang, Sixian, Peng, Xun, Li, Xiaoli, Yang, Ping, Xie, Linhao, Li, Yaochen, Du, Caiwen, Zhang, Guojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979100/
https://www.ncbi.nlm.nih.gov/pubmed/35391718
http://dx.doi.org/10.18632/oncotarget.28109
_version_ 1784681100998606848
author Liang, Sixian
Peng, Xun
Li, Xiaoli
Yang, Ping
Xie, Linhao
Li, Yaochen
Du, Caiwen
Zhang, Guojun
author_facet Liang, Sixian
Peng, Xun
Li, Xiaoli
Yang, Ping
Xie, Linhao
Li, Yaochen
Du, Caiwen
Zhang, Guojun
author_sort Liang, Sixian
collection PubMed
description
format Online
Article
Text
id pubmed-8979100
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-89791002022-04-06 Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin Liang, Sixian Peng, Xun Li, Xiaoli Yang, Ping Xie, Linhao Li, Yaochen Du, Caiwen Zhang, Guojun Oncotarget Correction Impact Journals LLC 2022-04-01 /pmc/articles/PMC8979100/ /pubmed/35391718 http://dx.doi.org/10.18632/oncotarget.28109 Text en Copyright: © 2022 Liang et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Liang, Sixian
Peng, Xun
Li, Xiaoli
Yang, Ping
Xie, Linhao
Li, Yaochen
Du, Caiwen
Zhang, Guojun
Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title_full Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title_fullStr Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title_full_unstemmed Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title_short Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
title_sort correction: silencing of cxcr4 sensitizes triple-negative breast cancer cells to cisplatin
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979100/
https://www.ncbi.nlm.nih.gov/pubmed/35391718
http://dx.doi.org/10.18632/oncotarget.28109
work_keys_str_mv AT liangsixian correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT pengxun correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT lixiaoli correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT yangping correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT xielinhao correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT liyaochen correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT ducaiwen correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin
AT zhangguojun correctionsilencingofcxcr4sensitizestriplenegativebreastcancercellstocisplatin

Ejemplares similares